AABPHARMA11 LTD
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-09-30 | 2023-09-30 |
|---|---|---|
| Total assets | £1.7k | — |
| Current assets | £8.3k | — |
| Cash | £2.6k | — |
| Debtors | £5.8k | — |
| Net assets | £1.7k | — |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (6 events)Click to expand
- 2025-06-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-01-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-05-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-09-21🏢Company incorporatedAs AABPHARMA11 LTD
- 2021-09-21➕BASHIR, Awais Ali appointeddirector
- 2021-09-21📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Awais Ali Bashir Individual · Scottish · DOB 07/1997 · age 29 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 21/09/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A & C PATON CONSULTING LIMITED→ SC876766 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| A FOOT AHEAD LTD→ SC703702 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| A.A. PODIATRY LIMITED→ SC246633 · est 2003 · no financials extracted | — | — | — | — | 23y | — | — |
| A1 CHIRO LTD→ SC367037 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ABERDEEN HOMECARE LTD→ SC747744 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ABIHEALTH SOLUTIONS LTD→ SC411465 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ACCN MEDICAL LIMITED→ SC624922 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ACE PLACE LTD→ SC705777 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ACJDAVIDSON LTD→ SC827188 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ACT COUNSELLING AND TRAINING SERVICES LTD→ SC791279 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ACTION FOR CHILDREN (SCOTLAND) LTD→ SC526474 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ADAM & MACEWEN LIMITED→ SC283627 · est 2005 · no financials extracted | — | — | — | — | 20y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.